Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 868 to 917 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 868\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sterol regulatory element binding protein cleavage-activating protein (srebp cleavage-activating protein) (scap). [source:swissprot;acc:q12770]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5595.65\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6173.23\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.10322\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 869\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent atp synthase beta chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p06576]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 870\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phosphatidylinositol 3-kinase regulatory beta subunit (pi3-kinase p85-beta subunit) (ptdins-3-kinase p85-beta). [source:swissprot;acc:o00459]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 871\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein bap28. [source:swissprot;acc:q9h583]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3956.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4364.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10313\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 872\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent epididymal secretory protein e1 precursor (niemann-pick disease type c2 protein) (epi-1) (he1) (epididymal secretory protein 14.6) (esp14.6). [source:swissprot;acc:q15668]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6781.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7480.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.1031\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 873\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent programmed cell death protein 5 (tfar19 protein) (tf-1 cell apoptosis related gene-19 protein). [source:swissprot;acc:o14737]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4749.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5237.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.1028\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 874\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ca2+-dependent endoplasmic reticulum nucleoside diphosphatase; apyrase; soluble calcium-activated nucleotidase scan-1. [source:refseq;acc:nm\_138793]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 9921.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 10941.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10278\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 875\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent steroid hormone receptor err2 (estrogen-related receptor, beta) (err-beta) (estrogen receptor-like 2) (err beta-2). [source:swissprot;acc:o95718]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 10263.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 11318.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10277\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 876\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent peroxisomal carnitine octanoyltransferase (ec 2.3.1.-) (cot). [source:swissprot;acc:q9ukg9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5644.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6223.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10249\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 877\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitotic spindle assembly checkpoint protein mad2b (mad2-like 2) (hrev7). [source:swissprot;acc:q9ui95]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5797.88\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6391.75\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.10243\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 878\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial 28s ribosomal protein s32 (s32mt) (mrp-s32) (ptd007) (hspc204). [source:swissprot;acc:q9y6g3]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 879\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nuclear pore complex protein nup88 (nucleoporin nup88) (88 kda nuclear pore complex protein). [source:swissprot;acc:q99567]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 880\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent peptide chain release factor 1, mitochondrial precursor (mrf-1). [source:swissprot;acc:o75570]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5166.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5694.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.1023\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 881\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent adp-ribosylation factor-like protein 7 (adp-ribosylation factor-like protein lak). [source:swissprot;acc:p56559]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5912.84\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6517.69\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.10229\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 882\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vacuolar atp synthase subunit d (ec 3.6.3.14) (v-atpase d subunit) (vacuolar proton pump d subunit) (v-atpase ac39 subunit) (v-atpase 40 kda accessory protein) (p39) (32 kda accessory protein). [source:swissprot;acc:p12953]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 883\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent adp-ribosylation factor-like protein 4. [source:swissprot;acc:p40617]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 884\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mannose-p-dolichol utilization defect 1 protein (suppressor of lec15 and lec35 glycosylation mutation homolog) (sl15). [source:swissprot;acc:o75352]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5167.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5695.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10224\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 885\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial translational release factor 1-like. [source:refseq;acc:nm\_019041]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5168.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5696.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10219\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 886\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent upstream binding protein 1 (lbp-1a). [source:refseq;acc:nm\_014517]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5903.18\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6506.32\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.10217\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 887\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription factor cp2; transcription factor cp2, alpha globin. [source:refseq;acc:nm\_005653]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 888\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lbp-9. [source:refseq;acc:nm\_014553]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 889\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent splicing factor, arginine/serine-rich 3 (pre-mrna splicing factor srp20) (x16 protein). [source:swissprot;acc:p23152]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 890\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tryptophan 2,3-dioxygenase (ec 1.13.11.11) (tryptophan pyrrolase) (tryptophanase) (tryptophan oxygenase) (tryptamin 2,3-dioxygenase) (trpo). [source:swissprot;acc:p48775]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5350.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5896.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10203\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 891\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lymphoid enhancer binding factor 1 (lef-1) (t cell-specific transcription factor 1-alpha) (tcf1-alpha). [source:swissprot;acc:q9uju2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5385.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5933.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10188\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 892\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cytoplasmic protein nck1 (nck adaptor protein 1) (sh2/sh3 adaptor protein nck-alpha). [source:swissprot;acc:p16333]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6784.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7475.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10182\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 893\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent e-1 enzyme. [source:refseq;acc:nm\_021204]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6603.09\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7274.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10171\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 894\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent parafibromin. [source:refseq;acc:nm\_024529]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4331.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4771.22\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.1016\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 895\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent heterogeneous nuclear ribonucleoprotein l (hnrnp l). [source:swissprot;acc:p14866]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 10247.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 11289\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 896\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent signal recognition particle receptor alpha subunit (sr-alpha) (docking protein alpha) (dp-alpha). [source:swissprot;acc:p08240]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5208.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5737.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10155\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 897\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histone deacetylase 2 (hd2). [source:swissprot;acc:q92769]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5929.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6531.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10153\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 898\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent multiple coagulation factor deficiency 2; neural stem cell derived neuronal survival protein; multiple coagulation factor deficiency protein 2. [source:refseq;acc:nm\_139279]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5929.55\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6531.52\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.10152\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 899\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dj153g14.2 (possible ca binding protein similar to nefa) (fragment). [source:sptrembl;acc:q9ujn8]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 900\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cg9578-like; yeast ypr037w and worm c02c2.6 predicted proteins-like. [source:refseq;acc:nm\_152902]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4713.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4279.17\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 901\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histone deacetylase 1 (hd1). [source:swissprot;acc:q13547]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5929.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6531.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10151\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 902\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent estrogen-related receptor gamma (estrogen receptor related protein 3) (err gamma-2). [source:swissprot;acc:o75454]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 10246.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 11285.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10147\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 903\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent red cell acid phosphatase 1, isozyme f (ec 3.1.3.2) (acp1) (low molecular weight phosphotyrosine protein phosphatase) (ec 3.1.3.48) (adipocyte acid phosphatase, isozyme alpha). [source:swissprot;acc:p24666]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4986.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5492.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10146\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 904\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent importin beta-3 subunit (karyopherin beta-3 subunit) (ran-binding protein 5). [source:swissprot;acc:o00410]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6167.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6785.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10031\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 905\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent steroid hormone receptor err1 (estrogen-related receptor, alpha) (err-alpha) (estrogen receptor-like 1). [source:swissprot;acc:p11474]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 10230.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 11256.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.1003\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 906\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ran-gtp binding protein (fragment). [source:sptrembl;acc:o60518]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6165.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6783.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10023\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 907\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ba305p22.3 (breast carcinoma amplified sequence 4). [source:sptrembl;acc:q8ndy6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 11852.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 10773.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10019\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 908\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent basic helix-loop-helix domain containing, class b, 5; trinucleotide repeat containing 20. [source:refseq;acc:nm\_152414]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 11848.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 10770.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10014\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 909\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent kinesin family member c3. [source:refseq;acc:nm\_005550]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5995.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6595.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.10005\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 910\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sipl protein. [source:refseq;acc:nm\_018269]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6522.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7175.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09999\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 911\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent prefoldin subunit 5 (c-myc binding protein mm-1) (myc modulator 1). [source:swissprot;acc:q99471]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4982.81\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5480.91\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.09996\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 912\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent prefoldin subunit 6 (protein ke2). [source:swissprot;acc:o15212]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 913\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ww domain binding protein 2 (wbp-2). [source:swissprot;acc:q969t9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5768.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6342.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09943\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 914\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cathepsin b precursor (ec 3.4.22.1) (cathepsin b1) (app secretase). [source:swissprot;acc:p07858]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6513.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7161\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.09942\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 915\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cytochrome b5 reductase b5r.2. [source:refseq;acc:nm\_016229]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6289.72\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6911.96\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.09893\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 916\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cytochrome b5 reductase 1 (b5r.1). [source:refseq;acc:nm\_016243]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 917\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nadh-cytochrome b5 reductase (ec 1.6.2.2) (b5r). [source:swissprot;acc:p00387]\vspace{3pt}}&&&\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/